ResMed

Healthcare | Medical Instruments & Supplies | USA
ResMed Tanks on Second-Quarter Revenue Miss

The company easily beats earnings expectations, but falls short on revenue.

The San Diego company reported a 9% increase in adjusted revenue to $651.1 million but lagged Wall Street's expectations of $667 million. The company did beat on earnings, however, posting a profit of $1 a share vs. expectations of 94 cents. 

...

Separately, the company announced that its board declared a quarterly cash dividend of 37 cents per share, payable on March 14 to shareholders of record on Feb. 7.

...

https://www.thestreet.com/investing/resm...s-14845820

ResMed's (RMD) Q1 Earnings Beat Estimates, Margins Expand

ResMed Inc. RMD announced first-quarter fiscal 2020 adjusted earnings per share (EPS) of 93 cents, up 14.8% year over year. The metric also beat the Zacks Consensus Estimate by 6.9%.

Reported EPS was 83 cents for the quarter under review, reflecting an increase of 13.7% from the year-ago period.

Revenues in the reported quarter increased 15.8% year over year (up 17% at constant exchange rate or CER) to $681.1 million. The figure surpassed the Zacks Consensus Estimate by 3.6%.


...

https://finance.yahoo.com/news/resmeds-r...03974.html